Publication: Severe enterocolitis secondary to ipilimumab and nivolumab with an excellent response to a single dose of infliximab.
| dc.contributor.author | Luque Carmona, Ana María | |
| dc.contributor.author | Ontanilla-Clavijo, Guillermo | |
| dc.contributor.author | Leo Carnerero, Eduardo | |
| dc.date.accessioned | 2023-02-09T09:43:50Z | |
| dc.date.available | 2023-02-09T09:43:50Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Immunotherapy is gaining significance in the management of oncological disease. It has demonstrated high levels of efficacy, though it also has hitherto unknown side effects, such as colitis. We present the first case of immune checkpoint inhibitor colitis (nivolumab+ipilimumab) refractory to corticoids treated in our hospital. | |
| dc.identifier.doi | 10.17235/reed.2020.6886/2020 | |
| dc.identifier.issn | 1130-0108 | |
| dc.identifier.pmid | 33054275 | |
| dc.identifier.unpaywallURL | https://doi.org/10.17235/reed.2020.6886/2020 | |
| dc.identifier.uri | http://hdl.handle.net/10668/16420 | |
| dc.issue.number | 11 | |
| dc.journal.title | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva | |
| dc.journal.titleabbreviation | Rev Esp Enferm Dig | |
| dc.language.iso | en | |
| dc.organization | Hospital Universitario Virgen del Rocío | |
| dc.page.number | 889-890 | |
| dc.pubmedtype | Case Reports | |
| dc.pubmedtype | Journal Article | |
| dc.rights.accessRights | open access | |
| dc.subject.mesh | Colitis | |
| dc.subject.mesh | Enterocolitis | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Infliximab | |
| dc.subject.mesh | Ipilimumab | |
| dc.subject.mesh | Nivolumab | |
| dc.title | Severe enterocolitis secondary to ipilimumab and nivolumab with an excellent response to a single dose of infliximab. | |
| dc.type | research article | |
| dc.type.hasVersion | VoR | |
| dc.volume.number | 112 | |
| dspace.entity.type | Publication |